Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Dec 05, 2019 16:10 ET
Zumiez Inc. Announces Fiscal 2019 Third Quarter Results
Zumiez Inc. (NASDAQ: ZUMZ) today reported results for the third quarter ended November 2, 2019. Total net sales for the third quarter ended November 2, 2019 (13 weeks) increased 6.1% to $264.0 million from $248.8 million in the quarter ended...
Dec 05, 2019 16:09 ET
Brinks Home Security to Present at Imperial Capital’s Security Investor Conference
Monitronics International, Inc. and its subsidiaries (doing business as Brinks Home Security™), (“Brinks Home Security” or the “Company”) (OTC: SCTY) today announced that it will present to attendees of the Imperial Capital 2019 Security Investors...
Dec 05, 2019 16:05 ET
AMMO, Inc. Participated in the Global SOF 2019 Modern Warfare Symposium
AMMO, Inc. (OTCQB: POWW) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, attended the Global SOF (GSOF) Modern Warfare Symposium event held November 19-22, 2019, in Fort Bragg,...
Dec 05, 2019 16:05 ET
Appian Corporation to Present at Barclays Global Technology, Media and Telecommunications Conference
Appian Corporation (NASDAQ: APPN), today announced that management will present at the Barclays Global Technology, Media and Telecommunications Conference in San Francisco, CA. This presentation is scheduled for Thursday, December 12th at 1:00 p.m....
Dec 05, 2019 16:05 ET
Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir
Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the publication with Merck, known as MSD outside the United States and Canada, of a paper in the prestigious peer-reviewed journal Science, detailing the development of...
Dec 05, 2019 16:05 ET
CrowdStrike Reports Record Fiscal Third Quarter 2020 Financial Results
CrowdStrike Holdings, Inc., (Nasdaq: CRWD), a leader in cloud-delivered endpoint protection, today announced financial results for the third quarter of its fiscal 2020, ended October 31, 2019. “Third quarter results well exceeded our expectations...
Dec 05, 2019 16:05 ET
Domo Announces Fiscal 2020 Third Quarter Financial Results
Domo, Inc. (Nasdaq: DOMO) today announced results for the fiscal 2020 third quarter ended October 31, 2019. Fiscal Third Quarter Results Total revenue was $44.8 million, an increase of 22% year over yearSubscription revenue was $37.8 million,...
Dec 05, 2019 16:05 ET
ESTA Reaches One Million Motiva Implants Milestone
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – announced its one millionth Motiva® implant in market. Juan José...
Dec 05, 2019 16:05 ET
FedNat Authorizes $10 Million Share Repurchase Program
FedNat Holding Company (NASDAQ: FNHC) (“FedNat” or the “Company”), an insurance holding company, today announced that its Board of Directors has authorized a new share repurchase program, under which the Company may repurchase up to $10 million of...
Dec 05, 2019 16:05 ET
Meridian Bancorp, Inc. Announces 14% Increase in Quarterly Dividend
Meridian Bancorp, Inc. (the “Company” or “Meridian”) (NASDAQ: EBSB), the holding company for East Boston Savings Bank, today declared a quarterly cash dividend of $0.08 per common share, an increase of $0.01 per common share or 14%, payable on...
Dec 05, 2019 16:05 ET
New Pacific Announces Grant of Restricted Share Units
New Pacific Metals Corp. (“New Pacific” or the “Company”) announces today that it has granted an aggregate total of 1,064,600 restricted share units of the Company ("RSUs") to certain eligible participants under the Company's share based...
Dec 05, 2019 16:05 ET
PetIQ, Inc. Provides Update on Wellness Center Openings
PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, provided an update on its year-to-date wellness center openings.  In November, the Company opened 34 new wellness centers for a total of 60...
Dec 05, 2019 16:05 ET
Photo Release -- WSFS Bank Sponsors Preston & Steve’s Camp Out for Hunger 2019, Donates $15,000 to Philabundance
WSFS Bank, the primary subsidiary of WSFS Financial Corporation (Nasdaq: WSFS), presented a $15,000 donation to Philabundance, the largest hunger relief organization in the Delaware Valley, as part of Preston & Steve’s Camp Out for Hunger 2019,...
Dec 05, 2019 16:05 ET
Prothena Announces Appointment of Oleg Nodelman to its Board of Directors
Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, announced today the appointment of Oleg Nodelman to its Board of Directors. “Oleg is a veteran biotechnology investor and advisor with deep roots in the biotechnology...
Dec 05, 2019 16:05 ET
Quotient Limited Reports Concordance Data from MDS Concept Study
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported positive concordance data for its MosaiQ™ Multiplex Molecular Disease Screening (MDS) Microarray confirming...
Dec 05, 2019 16:05 ET
Zoom Video Communications Reports Third Quarter Results for Fiscal Year 2020
Zoom Video Communications, Inc. (NASDAQ: ZM), a provider of video-first unified communications, today announced financial results for the quarter ended October 31, 2019. “Our third quarter was another strong performance for Zoom. Our execution...
Dec 05, 2019 16:01 ET
CORRECTION - McGrath RentCorp Quarterly Dividend Record Date
On December 4, 2019, the Board of Directors of McGrath RentCorp (NASDAQ:MGRC), a diversified business-to-business rental company declared a quarterly cash dividend of $0.375 per common share for the quarter ended December 31, 2019. The dividend...
Dec 05, 2019 16:01 ET
Providence Service Corporation Declares Cash Dividend on Convertible Preferred Stock
The Providence Service Corporation (Nasdaq: PRSC) today announced that its Board of Directors has declared a cash dividend on its 5.5%/8.5% Series A convertible preferred stock. The dividend is payable on January 2, 2020 to holders of record as of...
Dec 05, 2019 16:01 ET
Y-mAbs and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for Omburtamab
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today...
Dec 05, 2019 16:01 ET
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
Mechelen, Belgium; 5 December 2019, 22.01 CET – Galapagos NV (Euronext & NASDAQ: GLPG) has completed recruitment for the NOVESA Phase 2 clinical trial with GLPG1690. NOVESA is a double-blind, placebo-controlled Phase 2a trial evaluating the...